Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders?
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders?
Authors
Keywords
-
Journal
NEUROPSYCHOPHARMACOLOGY
Volume 40, Issue 2, Pages 259-267
Publisher
Springer Nature
Online
2014-09-26
DOI
10.1038/npp.2014.261
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Word to the Wise About Ketamine
- (2014) Alan F. Schatzberg AMERICAN JOURNAL OF PSYCHIATRY
- Central antinociception induced by ketamine is mediated by endogenous opioids and μ- and δ-opioid receptors
- (2014) Daniela da Fonseca Pacheco et al. BRAIN RESEARCH
- EFFECTS OF KETAMINE ON EXPLICIT AND IMPLICIT SUICIDAL COGNITION: A RANDOMIZED CONTROLLED TRIAL IN TREATMENT-RESISTANT DEPRESSION
- (2014) Rebecca B. Price et al. DEPRESSION AND ANXIETY
- Raphe AMPA receptors and nicotinic acetylcholine receptors mediate ketamine-induced serotonin release in the rat prefrontal cortex
- (2014) Naoya Nishitani et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression
- (2014) Paulo R. Shiroma et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Do the dissociative side effects of ketamine mediate its antidepressant effects?
- (2014) David A. Luckenbaugh et al. JOURNAL OF AFFECTIVE DISORDERS
- Extrasynaptic NMDA Receptor Involvement in Central Nervous System Disorders
- (2014) Matthew P. Parsons et al. NEURON
- Subanesthetic Ketamine Treatment Promotes Abnormal Interactions between Neural Subsystems and Alters the Properties of Functional Brain Networks
- (2014) Neil Dawson et al. NEUROPSYCHOPHARMACOLOGY
- Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses
- (2014) E. S. Gideons et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes
- (2014) A. McGirr et al. PSYCHOLOGICAL MEDICINE
- Dissociable effects of the noncompetitive NMDA receptor antagonists ketamine and MK-801 on intracranial self-stimulation in rats
- (2014) Todd M. Hillhouse et al. PSYCHOPHARMACOLOGY
- Rapid antidepressant effects and abuse liability of ketamine
- (2014) Chun Yang et al. PSYCHOPHARMACOLOGY
- Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine, in the novelty-suppressed feeding test
- (2014) Kenichi Fukumoto et al. PSYCHOPHARMACOLOGY
- Ketamine and damage to the urinary tract
- (2013) Dan Wood ADDICTION
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
- (2013) James W. Murrough et al. AMERICAN JOURNAL OF PSYCHIATRY
- Glutamate-Based Antidepressants: Preclinical Psychopharmacology
- (2013) Andrzej Pilc et al. BIOLOGICAL PSYCHIATRY
- Inhibition of Glycine Transporter-I as a Novel Mechanism for the Treatment of Depression
- (2013) Chih-Chia Huang et al. BIOLOGICAL PSYCHIATRY
- Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond
- (2013) John H. Krystal et al. BIOLOGICAL PSYCHIATRY
- Impact of Ketamine on Neuronal Network Dynamics: Translational Modeling of Schizophrenia-Relevant Deficits
- (2013) Bernat Kocsis et al. CNS Neuroscience & Therapeutics
- Ketamine Pharmacology: An Update (Pharmacodynamics and Molecular Aspects, Recent Findings)
- (2013) Georges Mion et al. CNS Neuroscience & Therapeutics
- Involvement of the GluN2A and GluN2B Subunits in Synaptic and Extrasynaptic N -methyl-d-aspartate Receptor Function and Neuronal Excitotoxicity
- (2013) Xianju Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Repeated S-ketamine Infusions in Therapy Resistant Depression: A Case Series
- (2013) Felix Segmiller et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Antidepressant Augmentation Using theN-Methyl-d-Aspartate Antagonist Memantine
- (2013) Eric G. Smith et al. JOURNAL OF CLINICAL PSYCHIATRY
- Acute Suppression of Spontaneous Neurotransmission Drives Synaptic Potentiation
- (2013) E. Nosyreva et al. JOURNAL OF NEUROSCIENCE
- Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans
- (2013) N R Driesen et al. MOLECULAR PSYCHIATRY
- Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects
- (2013) G Sanacora et al. MOLECULAR PSYCHIATRY
- Imaging Patients with Psychosis and a Mouse Model Establishes a Spreading Pattern of Hippocampal Dysfunction and Implicates Glutamate as a Driver
- (2013) Scott A. Schobel et al. NEURON
- Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept
- (2013) Carolyn I Rodriguez et al. NEUROPSYCHOPHARMACOLOGY
- NMDA Receptor Blockade by Ketamine Abrogates Lipopolysaccharide-Induced Depressive-Like Behavior in C57BL/6J Mice
- (2013) Adam K Walker et al. NEUROPSYCHOPHARMACOLOGY
- Pharmacological blockade of GluN2B-containing NMDA receptors induces antidepressant-like effects lacking psychotomimetic action and neurotoxicity in the perinatal and adult rodent brain
- (2013) Juan M. Lima-Ojeda et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Pomaglumetad methionil: No significant difference as an adjunctive treatment for patients with prominent negative symptoms of schizophrenia compared to placebo
- (2013) Virginia L. Stauffer et al. SCHIZOPHRENIA RESEARCH
- Brain damages in ketamine addicts as revealed by magnetic resonance imaging
- (2013) Chunmei Wang et al. Frontiers in Neuroanatomy
- Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Antidepressant Efficacy of Ketamine in Depressed Patients
- (2012) Gonzalo Laje et al. BIOLOGICAL PSYCHIATRY
- Ketamine for Depression: Where Do We Go from Here?
- (2012) Marije aan het Rot et al. BIOLOGICAL PSYCHIATRY
- On the Safety and Benefits of Repeated Intravenous Injections of Ketamine For Depression
- (2012) Pierre Blier et al. BIOLOGICAL PSYCHIATRY
- A Randomized Trial of a Low-Trapping Nonselective N-Methyl-D-Aspartate Channel Blocker in Major Depression
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
- (2012) James W. Murrough et al. BIOLOGICAL PSYCHIATRY
- Family history of alcohol dependence and antidepressant response to anN-methyl-D-aspartate antagonist in bipolar depression
- (2012) David A Luckenbaugh et al. BIPOLAR DISORDERS
- The Role of Memantine in the Treatment of Psychiatric Disorders Other Than the Dementias
- (2012) Gabriele Sani et al. CNS DRUGS
- A randomized add-on trial of high-dose d-cycloserine for treatment-resistant depression
- (2012) Uriel Heresco-Levy et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Correlation Between Different Levels of Placebo Response Rate and Clinical Trial Outcome in Major Depressive Disorder
- (2012) Nadia Iovieno et al. JOURNAL OF CLINICAL PSYCHIATRY
- Discriminative Stimulus Effects of Hallucinogenic Drugs: a Possible Relation to Reinforcing and Aversive Effects
- (2012) Tomohisa Mori et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Chronic Ketamine Administration Modulates Midbrain Dopamine System in Mice
- (2012) Sijie Tan et al. PLoS One
- Synaptic Dysfunction in Depression: Potential Therapeutic Targets
- (2012) R. S. Duman et al. SCIENCE
- Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression
- (2011) Hiroyuki Koike et al. BEHAVIOURAL BRAIN RESEARCH
- Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
- (2011) Nanxin Li et al. BIOLOGICAL PSYCHIATRY
- 1H-[13C]-Nuclear Magnetic Resonance Spectroscopy Measures of Ketamine's Effect on Amino Acid Neurotransmitter Metabolism
- (2011) Golam M.I. Chowdhury et al. BIOLOGICAL PSYCHIATRY
- Brain-Derived Neurotrophic Factor Val66Met Allele Impairs Basal and Ketamine-Stimulated Synaptogenesis in Prefrontal Cortex
- (2011) Rong-Jian Liu et al. BIOLOGICAL PSYCHIATRY
- Long-lasting, distinct changes in central opioid receptor and urinary bladder functions in models of schizophrenia in rats
- (2011) Orsolya Kekesi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Evaluation of sigma (σ) receptors in the antidepressant-like effects of ketamine in vitro and in vivo
- (2011) Matthew J. Robson et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Antagonism of stimulation-produced analgesia by naloxone and N-methyl-D-aspartate: role of opioid and N-methyl-D-aspartate receptors
- (2011) AK Mehta et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- mTOR activation is required for the antidepressant effects of mGluR2/3 blockade
- (2011) Jason M. Dwyer et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Potentiation of μ-opioid receptor-mediated signaling by ketamine
- (2011) Achla Gupta et al. JOURNAL OF NEUROCHEMISTRY
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
- (2011) Anita E. Autry et al. NATURE
- Reduced Dorsal Prefrontal Gray Matter After Chronic Ketamine Use
- (2010) Yanhui Liao et al. BIOLOGICAL PSYCHIATRY
- Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder
- (2010) Nancy DiazGranados et al. JOURNAL OF CLINICAL PSYCHIATRY
- Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
- (2010) Giles E. Hardingham et al. NATURE REVIEWS NEUROSCIENCE
- Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats
- (2010) Christina L. Nemeth et al. PSYCHOPHARMACOLOGY
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
- (2009) Marije aan het Rot et al. BIOLOGICAL PSYCHIATRY
- Memantine binding to a superficial site on NMDA receptors contributes to partial trapping
- (2009) Shawn E. Kotermanski et al. JOURNAL OF PHYSIOLOGY-LONDON
- Gamma and Delta Neural Oscillations and Association with Clinical Symptoms under Subanesthetic Ketamine
- (2009) L Elliot Hong et al. NEUROPSYCHOPHARMACOLOGY
- Adverse events associated with ketamine for procedural sedation in adults
- (2008) Reuben J. Strayer et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Family History of Alcohol Dependence and Initial Antidepressant Response to an N -methyl-D-aspartate Antagonist
- (2008) Laura E. Phelps et al. BIOLOGICAL PSYCHIATRY
- An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
- (2008) Sheldon H. Preskorn et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors
- (2007) Sungho Maeng et al. BIOLOGICAL PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now